Skip to main content
Realcan Pharmaceutical Group Co.,Ltd. logo

Realcan Pharmaceutical Group Co.,Ltd. — Investor Relations & Filings

Ticker · 002589 ISIN · CNE1000013X5 LEI · 300300YI5IV3FBRRSJ48 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,678 across all filing types
Latest filing 2022-04-29 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 002589

About Realcan Pharmaceutical Group Co.,Ltd.

https://www.realcan.cn

Realcan Pharmaceutical Group Co., Ltd. specializes in the distribution of pharmaceutical products, medical devices, and healthcare consumables. The company operates an extensive supply chain network, providing integrated logistics and distribution services primarily to medical institutions and healthcare providers. Its core operations include the procurement, storage, and delivery of a wide range of medical supplies, supported by advanced information management systems and cold-chain logistics capabilities. Realcan also offers value-added services such as hospital supply chain optimization, third-party logistics, and financial solutions tailored to the healthcare industry. By focusing on a direct-to-hospital distribution model, the company aims to enhance the efficiency of medical supply procurement and ensure the timely delivery of critical healthcare products.

Recent filings

Filing Released Lang Actions
董事会决议公告
Regulatory Filings Classification · 95% confidence The document is a formal announcement of resolutions passed at the 21st meeting of the 4th Board of Directors of Ruikang Pharmaceutical Group Co., Ltd. It includes approvals of the 2021 Annual Report and its summary, the 2021 General Manager's Work Report, the 2021 Board Work Report, the 2021 Financial Final Accounts and 2022 Budget, internal control reports, profit distribution plan, amendments to the company charter, and the 2022 Q1 report. The document states these reports will be submitted to the 2021 Annual General Meeting for approval. The document is a board meeting resolution announcement, not the reports themselves. It is a regulatory announcement about board decisions and upcoming shareholder meeting agenda items, including the annual report and dividend proposals. The document length is short (2175 characters), and it does not contain the full annual report or financial statements but references them. Therefore, it is best classified as a Regulatory Filing (RNS) because it is an official announcement of board resolutions and meeting decisions rather than the full Annual Report (10-K) or Interim Report (IR).
2022-04-29 Chinese
2021年年度审计报告
Audit Report / Information Classification · 100% confidence The document is titled '年度审计报告' which translates to 'Annual Audit Report' and is issued by an accounting firm (天圆全会计师事务所). It contains detailed financial statement audit information, including balance sheet data and audit opinions. The presence of audit report number, audit opinion type (unqualified opinion), and detailed financial data confirms this is a standalone audit report rather than a full annual report or other document type. The document length is substantial (15,000 characters), indicating it is the full report, not just an announcement or certification. Therefore, the document fits the category of Audit Report / Information (AR). FY 2021
2022-04-29 Chinese
营业收入扣除情况的专项核查意见
Regulatory Filings
2022-04-29 Chinese
关于为控股及全资子公司提供担保进展情况的公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement from 瑞康医药集团股份有限公司 regarding the progress of guarantees provided for its holding and wholly-owned subsidiaries. It includes specific financial figures, guarantee amounts, relationships between guarantors and guaranteed parties, and financial status of the guaranteed companies. The document is an official announcement about the company's external guarantees, including amounts, types, and related financial data. It does not contain a full annual or interim financial report, audit report, or earnings release. It is not a call transcript, AGM material, or management report. The content is focused on a specific corporate financing-related update about guarantees, which fits best under Capital/Financing Update (CAP). The document length is 6693 characters, which is substantive and contains detailed financial data related to guarantees, not just a brief announcement or certification. Therefore, the classification is CAP with high confidence.
2022-04-25 Chinese
股票交易异常波动公告
Regulatory Filings Classification · 95% confidence The document is a stock trading abnormal fluctuation announcement by 瑞康医药集团股份有限公司. It discusses the unusual price movements of the company's stock over several days, the company's investigation into the cause, confirmation of no undisclosed material information, and risk warnings to investors. There is no financial data, no report attached or referenced as being published, and no mention of annual or quarterly reports, earnings, or management changes. The document is a regulatory announcement related to stock price behavior and compliance with disclosure rules, fitting the category of a Regulatory Filing (RNS). The document length is short (1317 characters), and it is not a report itself but an announcement of a regulatory nature.
2022-04-11 Chinese
关于实际控制人部分股份解除质押的公告
Major Shareholding Notification Classification · 95% confidence The document is a public announcement regarding the release of pledged shares by the actual controller of the company, including detailed data on share pledges and risks related to shareholding. It does not contain financial statements, audit information, or management discussion. It is a disclosure about share pledge status and shareholder information, which fits the category of Major Shareholding Notification (MRQ). The document length is short and focused on shareholding changes, not a full report or announcement of a report publication.
2022-04-08 Chinese

Browse filings by year

16 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.